Search results
Farcast Biosciences develops pioneering anthropic (true-to-human) biological systems, data, and Artificial Intelligence (AI) to decipher the true complexities of human tumor dynamics. And make cancer treatment more predictive and precise.
- Publications
38th Annual Meeting SITC Pre-Selection of patients who would...
- News
Farcast Biosciences and the University of West Florida have...
- Farcast TruTumor
Farcast's proprietary techniques ensure that every tumor...
- Farcast TruSign
Farcast's TruSign technology comprehensively combines...
- Therapeutics Development
Scout New Indications. Translational Services, Precision...
- Diagnostics Development
The Farcast platform has a proven ability to collect...
- Contact
Contact Farcast, Reach out, Query. Thanks, we will be in...
- AACR 2023 Poster
Using Farcast's TruTumor technology, tumors from 6 HNSCC...
- Publications
About Us | Farcast Biosciences. > 23,000 TUMORS ANALYZED. TALK TO US. 10 Years And Counting. Our journey to understand human tumor histoculture began over a decade ago in the Boston area and we have consistently invested in learning and deciphering the complex world of human tumor microenvironments.
Farcast Biosciences | 10,113 followers on LinkedIn. 24,000 human tumors and counting - building the most precise functional precision tumor microdynamics platform | Farcast is human tumor...
Scout New Indications. Translational Services, Precision Guided Clinical Trials, Captive Tumor Biology Centers, Tumor Microdynamics Big Data and AI.
May 23, 2022 · Farcast Biosciences's unique and proprietary technology uses fresh human tumor samples cultured in a proven system that recreates TiME (Tumor immune MicroEnvironment) ex vivo.
Developer of a human tumor micro dynamics (HTMD) platform designed to treat human tumors. The company's platform generates and mines tumor micro dynamics (TMD) response data for high-fidelity, multimodal, human-relevant translational evidence and insights that enable precision therapeutics and diagnostics development using fresh human tumors ...
May 25, 2022 · California: Crosscope Inc. and Farcast Bioscience LLC have developed a unique and differentiated human tumour histoculture platform that can preserve the entire architecture of the human tumour microenvironment.